Hepatobiliary and Pancreatic Surgery and Transplants
At the Hepatobiliary and Pancreatic Surgery and Transplant Department, we dedicate ourselves to hepatic (liver), pancreatic and biliary surgery, as well as cancer surgery. This mainly involves surgery related to the surgical and onco-surgical treatment of tumours or liver metastases, liver and bowel transplants in children and adults, and intestinal transplants. Our Children’s Liver Transplant Programme is the only one of its kind in Catalonia, and one of just five in Spain. Our excellent results make us a national leader.
The Hepatobiliary and Pancreatic Surgery and Transplant Department is highly specialised, and is independent of the General Surgery Department, which is not very common in general surgery departments. We are organised into two sections: one section devoted mainly to liver surgery and liver and intestine transplants, and another aimed at pancreatic surgery and advanced laparoscopic surgery.
Vall d'Hebron was the first health centre in Spain to carry out a paediatric liver transplant in 1985. With more than 30 years of accumulated experience acquired since the first transplant was carried out, the hospital is home to an amazing group of professionals: anaesthetists, intensivists, radiologists, gastroenterologists, hepatologists and more, all trained to treat the most complex cases with very high survival rates. This survival rate is more than 90% at five and six years after the transplant. We are deeply proud that we have been able to achieve such figures.
To do so, and to offer the best service to our patients, we work closely with other hospital departments, mainly with Internal Medicine and Hepatology, Intensive Care, Oncology, Gastroenterology, Radiology and Pathological Anatomy.
Portfolio of services
- Surgical treatment of primary liver tumours (resection, radiofrequency, chemoembolisation).
- Onco-surgical treatment of hepatic metastases of colorectal cancer
- Onco-surgical treatment of hepatic metastases in non-colorectal cancer
- Onco-surgical treatment of hepatic metastases in neuroendocrine tumours
- Surgery of benign liver tumours
- Portal hypertension surgery
- Haemostatic surgery and techniques in liver trauma
- Surgery of refractory ascites with the implantation of new devices
- Surgery of hepatic vascular exclusion for hepatic regional chemotherapy treatment
- Onco-surgical treatment of hilar cholangiocarcinoma (T. Klatskin)
- Onco-surgical treatment of cholangiocarcinoma of the main biliary tract
- Treatment of cholecystitis
- Surgical treatment of biliary lithiasis (colelitiasis and coledocolitiasis) and complications
- Endoscopic treatment of lithiasis of the main biliary tract
- Biliodigestive derivations
- Onco-surgical treatment of pancreatic adenocarcinoma
- Onco-surgical treatment of other pancreatic tumours (cysts and neuroendocrines)
- Onco-surgical treatment of tumours in the periampullary region
- Surgical treatment of benign pancreatic tumours
- Treatment of pancreatitis and its complications
Liver and intestine transplant
- Liver transplant from donors in brain death
- Split liver transplant (adult and infant)
- Liver transplant HCV+ donors
- Domino liver transplants
- Liver transplants in HIV+ patients
- Liver transplants in patients with portal thrombosis
- Auxiliary liver transplant
- Intestinal transplant
- Isolated intestinal transplant
- Hepatointestinal transplant
- Multivisceral transplant
García Del Campo
The head of the Hepatobiliary and Pancreatic Surgery and Transplant Department at Vall d'Hebron University Hospital, Dr. Ramon Charco, explains the evolution of a Department that successfully treats both adults and children.
Vall d’Hebron’s Paediatric Intensive Care Unit was launched in 1968. Dr. Joan Sauleda, who was its first head, recalls the evolution that led to creating the pioneering Intensive Care Unit, which today, directed by Dr. Joan Balcells, is still the biggest in Catalonia.
The pathologists at Vall d’Hebron University Hospital are not like those you see in American films and TV series. They are better. Their job enables a vital diagnosis to be made when it comes to deciding on patient treatment. They are an essential part of the hospital mix, according to the head of the Pathological Anatomy Department, Santiago Ramon y Cajal.
The Vall d’Hebron Medical Oncology Department witnessed a vital moment in its trajectory when Dr. Josep Baselga joined in 1996. He laid the first stone of the current Department, now directed by Dr. Josep Tabernero, and converted the hospital into a world-leading centre.
Rosalia Moure arrived at Vall d’Hebron University Hospital in 1967. She spent her entire working life in the linen and laundry department of the Hospital. Rosalia Moure has witnessed the Hospital’s big transformations, from dictatorship to democracy and from analogue to digital systems.
Dr. Josep Sánchez de Toledo Codina, head of the Paediatric Haematology and Oncology Department, tells us about a Department that has laid the foundations for the specialism in Spain. He also remembers the evolution of transplants from haematopoietic stem cells and progenitors, from the beginning, buying the material at a shop in Barcelona city centre, to the more than 1,200 transplants that have now been performed.
Dr. Francesc Bosch, Head of the Haematology Department, talks about the complexity of the Department, which has turned Vall d’Hebron into a reference centre in haematology thanks to its commitment to transplants and the use of new treatments. The Clinical Trials Unit helps a lot, giving access to treatments for complex patients.
The Master's Degree in Biomedical and Translational Research is an official programme created to train researchers with the requisite combination of scientific knowledge and skills to contribute to the future success of biomedical research.
Fermín Fernández Álvarez, Porter Coordinator, explains the importance of the role these professionals play in the hospital. After 36 years at Vall d’Hebron, Fermín is a real master of the ways things are done. He says that a porter has to combine humility, discretion and safety with a single goal: that patients receive human and friendly treatment.